オーストラリアにおける NJA-730 の臨床第１相試験完了のお知らせ
Location: United States, California, Burlingame
Investors 1
| Date | Name | Website |
| - | Mitsui Glo... | mitsui-glo... |
Mentions in press and media 1
| Date | Title | Description |
| 09.01.2019 | NapaJen Pharma Closes $12.4M Series C Financing | NapaJen Pharma, Inc., a Burlingame, CA-based biotherapeutics company leveraging its proprietary immune cell-targeted oligonucleotide delivery technology to develop novel immunotherapeutic agents, closed a $12.4m Series C financing. The roun... |